1/62
Looks like no tags are added yet.
Benign brain tumor characteristic
Noncancerous
Malignant brain tumor characteristic
Cancerous
Meningiomas origin
Encapsulated tumor of arachnoid cells in the meninges.
Meningiomas growth rate
Slow growing.
Most common benign brain tumor
Meningiomas.
Meningioma demographics
More common in middle-age adult women.
Meningiomas treatment
Surgery for symptomatic tumors.
Pituitary adenomas classification
Typically benign tumors of the pituitary gland.
Pituitary adenoma pressure on optic chiasm
Bitemporal hemianopsia and loss of peripheral vision.
Pituitary adenoma pressure on 3rd ventricle
Hydrocephalus and increased intracranial pressure (ICP).
Hypothalamus involvement signs from pituitary adenoma
Sleep disruption, appetite changes, and temperature dysregulation.
Hormones hypersecreted by pituitary adenomas
Prolactin, growth hormone, ACTH, and/or TSH.
Prolactin hypersecretion effect in females
Amenorrhea or galactorrhea.
Prolactin hypersecretion effect in males
Impotence and hypogonadism.
Growth hormone hypersecretion condition
Acromegaly.
Acromegaly physical signs
Enlarged hands and feet, and facial feature distortion.
ACTH hypersecretion condition
Cushing's disease with overproduction of cortisol.
Cushing's disease physical signs
Central obesity, purple striae, and ecchymoses.
TSH hypersecretion effect
Hyperthyroidism.
Acoustic neuromas origin
Develop from cells in the myelin sheath.
Acoustic neuromas cranial nerve effect
Most often affects cranial nerve VIII.
Acoustic neuroma symptoms from CN VIII
Hearing loss, tinnitus, vertigo, and gait imbalance.
Acoustic neuroma facial pain cause
Compression of cranial nerve V.
Astrocytomas origin
Supportive tissue, glial cells, and astrocytes.
Astrocytoma malignancy grade
Low-moderate grade malignancy.
Astrocytomas removal challenge
Infiltrative and cannot be totally removed.
Astrocytomas treatment methods
Surgery, radiation therapy, and/or chemotherapy.
Glioblastoma multiforme origin
Develops from glioblasts (primitive stem cells).
Most aggressive primary brain tumor
Glioblastoma multiforme.
Glioblastoma multiforme grade
Grade III to IV poorly differentiated.
Glioblastoma multiforme prognosis
Poor prognosis despite multimodal treatment.
Frontal lobe tumor effects
Alterations in personality, mood or behavior, impulsivity, decreased concentration, agitation, aggression, difficulty with reasoning/problem-solving, unilateral weakness, and seizures.
Parietal lobe tumor effects
Contralateral decreased sensations, impaired spatial awareness, and difficulty with language, reading, and writing.
Temporal lobe tumor effects
Seizures, memory deficits, unilateral numbness or weakness, and difficulty hearing or speaking.
Occipital lobe tumor effects
Visual field deficits, loss of vision, and impaired ability to identify objects.
Cerebellar tumor effects
Impairments in balance, coordination, movement and fine motor skills, dizziness, ataxia, staggering gait, nystagmus, headache, and vomiting.
Brainstem tumor effects
Cranial nerve deficits, complex motor and sensory function impairments, seizures, and respiratory and cardiac dysfunction.
Monro-Kellie hypothesis
An increase in volume of any skull component leads to increased ICP unless another component decreases its volume to compensate.
Earliest indicator of worsening ICP
Change in level of consciousness such as restlessness, confusion, or drowsiness.
Headache characteristics in increased ICP
Dull, constant throbbing, worse in early morning, and increased with coughing, straining, or sudden movement.
Visual disturbances in increased ICP
Optic disc swelling, papilledema, decreased visual acuity, diplopia, hemianopsia, blindness, and sluggish pupil changes.
Late signs of increased ICP
Fixed or dilated pupils, decorticate or decerebrate posturing, coma, and brain herniation.
Cushing's Triad
Bradycardia, widened pulse pressure, hypertension, and irregular respirations.
Chemotherapy challenge in brain tumors
Difficulty getting across the blood-brain barrier.
Bevacizumab (Avastin)
Vascular endothelial growth factor inhibitor used in brain tumor treatment.
Dexamethasone in brain tumors
Corticosteroid used to relieve headaches, improve level of consciousness, and reduce inflammation and cerebral edema.
Osmotic diuretics in increased ICP
Mannitol and hypertonic saline used to decrease fluid in the brain and lower ICP; vomiting increases ICP.
Burr holes purpose
Opening made in skull with a drill to remove fluid or blood and acutely relieve pressure, not to treat the tumor.
Ventriculo-peritoneal shunt
Device that redirects CSF to another area (such as the sterile peritoneal cavity) when CSF is unable to drain.
Stereotactic surgery characteristics
Computer-guided single port procedure with a probe using extensive prior imaging and brain mapping to target precise areas.
Craniectomy
Removal of a section of the skull to relieve pressure and create room for the brain to swell without herniating.
Craniectomy post-operative care
Do not position the patient on the operative side, place signs in the room, and fit for a protective helmet for getting out of bed.
Transsphenoidal hypophysectomy hormone effects
Permanent loss of pituitary hormones (like TSH and ACTH) requiring lifelong replacement of thyroid hormones, sex hormones, and glucocorticoids.
Post-op transsphenoidal hypophysectomy precautions
No nose blowing for at least 48 hours, avoid coughing, sneezing, or straining, and keep HOB elevated.
Halo sign in CSF leak
Blood in the center with a yellowish ring around the outside, indicating a CSF leak.
Postoperative brain surgery priority assessments
Airway and oxygenation, neurologic status/exams, signs of increased ICP, fluid and electrolyte balance, and seizure precautions.
Postoperative brain surgery positioning
Head of bed elevated 30 to 45 degrees with head midline, avoiding neck flexion and rotation.
Primary brain tumors origin
Originate in brain tissue
Primary brain tumors classification
Classified by tissue which arise from
Primary brain tumors metastasis
Rarely metastasize outside CNS
Secondary brain tumors origin
Metastasize from other sites
Secondary brain tumor sites
Lung, breast, lower GI tract, pancreas, kidney, skin
Secondary brain tumors frequency
2x more common than primary brain tumors